Investment Analysts’ Recent Ratings Updates for DENTSPLY SIRONA (XRAY)

A number of research firms have changed their ratings and price targets for DENTSPLY SIRONA (NASDAQ: XRAY):

• 3/13/2025 – DENTSPLY SIRONA had its price target lowered by analysts at Mizuho from $21.00 to $18.00. They now have a “neutral” rating on the stock.
• 3/13/2025 – DENTSPLY SIRONA had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 2/28/2025 – DENTSPLY SIRONA had its price target lowered by analysts at Barrington Research from $24.00 to $20.00. They now have an “outperform” rating on the stock.
• 2/28/2025 – DENTSPLY SIRONA had its price target lowered by analysts at Robert W. Baird from $22.00 to $20.00. They now have a “neutral” rating on the stock.
• 2/28/2025 – DENTSPLY SIRONA was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 2/28/2025 – DENTSPLY SIRONA had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $19.00. They now have an “equal weight” rating on the stock.
• 2/28/2025 – DENTSPLY SIRONA had its price target lowered by analysts at Needham & Company LLC from $25.00 to $23.00. They now have a “buy” rating on the stock.
• 2/18/2025 – DENTSPLY SIRONA was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 2/14/2025 – DENTSPLY SIRONA is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $20.00 price target on the stock.
• 2/11/2025 – DENTSPLY SIRONA had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.
• 2/7/2025 – DENTSPLY SIRONA was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 1/30/2025 – DENTSPLY SIRONA had its price target raised by analysts at Needham & Company LLC from $23.00 to $25.00. They now have a “buy” rating on the stock.
• 1/23/2025 – DENTSPLY SIRONA was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $20.00 price target on the stock, down previously from $30.00.

DENTSPLY SIRONA Stock Performance

XRAY opened at $15.56 on Monday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company’s fifty day moving average price is $18.22 and its two-hundred day moving average price is $20.81. DENTSPLY SIRONA Inc. has a 1-year low of $14.77 and a 1-year high of $33.72. The company has a market cap of $3.10 billion, a price-to-earnings ratio of -7.52, a PEG ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.11%. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors have recently made changes to their positions in the company. Vise Technologies Inc. bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth $195,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of DENTSPLY SIRONA by 13.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock worth $10,466,000 after acquiring an additional 65,308 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth $24,571,000. Tidal Investments LLC grew its stake in shares of DENTSPLY SIRONA by 15.5% in the 4th quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier’s stock worth $488,000 after acquiring an additional 3,449 shares in the last quarter. Finally, True Wealth Design LLC grew its stake in shares of DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 1,950 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.